piamprizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for piamprizumab, covering 2021-05-21 to 2021-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]